{
  "12058581-DS-28": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nHouse Dust / dogs\n \nAttending: ___\n \n___ Complaint:\n___ male history of HTN, CKD (baseline Cr 1.7-2.0),\nparoxysmal AF (on apixaban), severe COPD secondary to alpha-1\nantitrypsin deficiency (not on home O2) who presented to OSH\n___) with dyspnea and hypoxemia likely secondary\nto community-acquired pneumonia with concomitant COPD\nexacerbation.\n \nMajor Surgical or Invasive Procedure:\nPICC line placed ___. PICC removed ___.\n\n \nHistory of Present Illness:\nPatient reports that he has had a productive cough for the last \n4\ndays. He presented for scheduled follow-up with his outpatient\npulmonologist yesterday at which time he had a mild cough but no\nother overt symptoms. He was ordered for a CXR but declined. He\nreturned to his home on ___ on ___ but woke up\nthis morning with shortness of breath and hypoxemia. He measured\nhis oxygen at rest and found to be in the mid-80s while normally\nhe is in the mid to high ___ at rest. He also had rigors, but no\ndocumented fevers. No sick contacts or recent travel. He denies\nchest pain or palpitations. Has baseline lower extremity edema\nwhich is stable. \n \nPast Medical History:\nAlpha-1 antitrypsin deficiency\nGOLD IV COPD (on intermittent home O2; recently on a prolonged \nprednisone taper)\ntracheobronchomalacia\nRecurrent pneumonia (per his pulmonologist's preference, he has \nbeen treated with vanc/cefepime in order to obtain rapid control \nof infection, as he is usually very slow to recover)\nParoxysmal a-fib (on apixaban; CHA2DS-VASc = 4 for age, DM, HTN)\nHTN\nDM\nCKD stage IIIB (w/ proteinuria; presumed secondary to DM)\nBPH (s/p TURP ___\nhypotonic bladder \nnephrolithiasis\nGout\nDepression\ncellulitis in left arm Bactrim and Keflex.\n \nSocial History:\n___\nFamily History:\nFather-deceased ___ ___ disease, prostate ca. \nMother-deceased ___ cancer.\n \nPhysical Exam:\nPHYSICAL EXAM:\nVITALS: 24 HR Data (last updated ___ @ 2321)\n    Temp: 98.4 (Tm 98.4), BP: 160/70 (144-164/68-89), HR: 52\n(52-76), RR: 18, O2 sat: 98% (90-98), O2 delivery: 3L  \nGENERAL: Alert and interactive, sitting in the chair. On RA.\nHEENT: Sclera anicteric and without injection. MMM.\nNECK: JVP\nCARDIAC: Distant heart sounds. regular rate, regular rhythm.\nAudible S1 and S2. No murmurs/rubs/gallops.\nLUNGS: Very distant lung sounds. Expiratory wheezes in LLL only,\nimproved from prior. \nABDOMEN: Normal bowels sounds, NTND. No organomegaly.\nEXTREMITIES: No clubbing, cyanosis. Bilateral 2+ pitting edema \nto\nthe knees. Pulses DP/Radial 2+ bilaterally.\nNEUROLOGIC: AOx3. Moving all 4 limbs spontaneously. Face\nsymmetric.\n\nDISCHARGE EXAM \nGENERAL: Alert and interactive, anxious appearing, sitting in \nthe\nchair. On RA.\nHEENT: Sclera anicteric and without injection. MMM.\nNECK: JVP\nCARDIAC: Distant heart sounds. regular rate, regular rhythm.\nAudible S1 and S2. No murmurs/rubs/gallops.\nLUNGS: Very distant lung sounds. Expiratory wheezes in LLL only,\nimproved from prior. \nABDOMEN: Normal bowels sounds, NTND. No organomegaly.\nEXTREMITIES: No clubbing, cyanosis. Bilateral 2+ pitting edema \nto\nthe knees, worsened from prior. Pulses DP/Radial 2+ bilaterally.\nNEUROLOGIC: AOx3. Moving all 4 limbs spontaneously. Face\nsymmetric.\n \nPertinent Results:\n___ 04:45PM BLOOD WBC-19.7* RBC-3.86* Hgb-11.8* Hct-37.9* \nMCV-98 MCH-30.6 MCHC-31.1* RDW-14.8 RDWSD-52.4* Plt ___\n___ 04:45PM BLOOD Neuts-91.7* Lymphs-3.3* Monos-4.2* \nEos-0.0* Baso-0.3 Im ___ AbsNeut-18.07* AbsLymp-0.65* \nAbsMono-0.83* AbsEos-0.00* AbsBaso-0.05\n___ 09:10AM BLOOD WBC-13.4* RBC-3.41* Hgb-10.4* Hct-32.6* \nMCV-96 MCH-30.5 MCHC-31.9* RDW-14.6 RDWSD-50.4* Plt ___\n___ 04:45PM BLOOD Plt ___\n___ 09:10AM BLOOD Plt ___\n___ 04:45PM BLOOD Glucose-235* UreaN-45* Creat-2.0* Na-140 \nK-5.0 Cl-107 HCO3-22 AnGap-11\n___ 09:10AM BLOOD Glucose-120* UreaN-44* Creat-2.2* Na-140 \nK-4.4 Cl-100 HCO3-27 AnGap-13\n___ 04:45PM BLOOD cTropnT-0.06*\n___ 12:31PM BLOOD Calcium-8.8 Phos-2.5* Mg-1.9\n___ 09:10AM BLOOD Calcium-9.0 Phos-4.2 Mg-1.7\n___ 04:16PM BLOOD ___ pO2-56* pCO2-57* pH-7.23* \ncalTCO2-25 Base XS--4 Comment-GREEN TOP\n___ 05:16PM BLOOD ___ Temp-36.9 pO2-72* pCO2-50* \npH-7.29* calTCO2-25 Base XS--2\n___ 09:25AM BLOOD Type-MIX pO2-112* pCO2-47* pH-7.33* \ncalTCO2-26 Base XS--1 Comment-GREEN TOP\n___ 05:16PM BLOOD Lactate-1.4\n\n___ 4:45 pm BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n\n___ 8:00 pm SPUTUM      Source: Expectorated. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      >25 PMNs and >10 epithelial cells/100X field. \n      Gram stain indicates extensive contamination with upper \nrespiratory\n      secretions. Bacterial culture results are invalid. \n      PLEASE SUBMIT ANOTHER SPECIMEN. \n\n   RESPIRATORY CULTURE (Final ___: \n      TEST CANCELLED, PATIENT CREDITED.\n\n___ 8:51 pm URINE      Source: ___. \n\n                            **FINAL REPORT ___\n\n   Legionella Urinary Antigen  (Final ___: \n      NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. \n           (Reference Range-Negative). \n      Performed by Immunochromogenic assay. \n\n___ 4:48 pm MRSA SCREEN      Source: Nasopharyngeal \naspirate. \n\n                            **FINAL REPORT ___\n\n   MRSA SCREEN (Final ___:    No MRSA isolated.\n\nREPORTS \n___ Imaging CHEST (PORTABLE AP) \nRight PICC line tip is at the level of lower SVC.  Heart size \nand mediastinum are stable.  Left basal consolidation and right \nbasal opacity noted.  No  appreciable pleural effusion or \npneumothorax.  Findings are concerning for  multifocal pneumonia \nwith potential progression bilaterally. \n  \n\n \nBrief Hospital Course:\n___ male with history of HTN, CKD (baseline Cr 1.7-2.0), \nparoxysmal atrial fibrillation (on apixaban), severe COPD \nsecondary to alpha-1 antitrypsin deficiency (not on home O2), \nwho presented to ___ with dyspnea and \nacute hypoxic respiratory failure, likely secondary to \ncommunity-acquired pneumonia with concomitant acute COPD \nexacerbation. \n\nACUTE/ACTIVE ISSUES:\n====================\n#Acute hypoxicc respiratory failure \n#Acute exacerbation of severe COPD \n#Pneumonia\nIn the setting of a few days of productive cough and worsening \ndyspnea from baseline, patient presented to ___ \nwith severe dyspnea and inability to speak in full sentences. \nResponded well to BiPAP and transitioned to 3L. CXR there showed \nnew L lobe infiltrates concerning for acute pneumonia likely \nprecipitating exacerbation of severe COPD. Low suspicion for PE \nas patient was anti-coagulated. Troponin elevated to 0.06 but in \nthe setting of CKD without chest pain or ischemic EKG changes. \nHe was started on vancomycin and cefepime at ___ \n(___) and continued on this on admission to ___. Last year he \nhad pneumonia and was on IV vancomycin + cefepime through ___ \nline for 10-day course. Dr. ___ pulmonologist) \nfollows him closely and has managed him on vancomycin + cefepime \nin the past. Sputum gram stain and culre returned contaminated. \nUrine strep/legionella antigens were negative. MRSA swab was \nnegative. On ___, the was broadened to vancomycin/zosyn as he \nhad 2 aspiration events in setting of coughing spells with new \nopacity visualized on repeat CXR despite being on vancomycin and \nCefepime. His vancomycin was subsequently stopped on ___ given \nnegative MRSA. His last day of Zosyn was ___ for a total 8 day \ncourse. He was started on azithromycin on ___ for a 5 day \ncourse. He was started on prednisone 40 mg daily and discharged \non a prolonged taper. He was also treated with duonebs and \nalbuterol PRN. He required 3L O2 (normally only requires at \nnight) throughout the day while recovering.  His ambulatory O2 \nsaturation was in low ___ on room air at day of discharge.\n\n#Lower Leg Edema \nPatient said that he takes his torsemide because of venous \nstasis edema. Per Dr. ___ visit, edema is \nprobably multifactorial including peripheral venous disease, \nprobably a component of diastolic heart failure with a \ncontribution also by his renal disease. He was given 40 mg of \nTorsemide on ___ in setting of worsening ___ edema as patient \nwas refusing initially. He was resumed on his 20 mg daily on \ndischarge. \n\n#Type II DM\nDiet controlled. Blood glucose is elevated to 235 on admission, \nlikely exacerbated by steroids. Patient declined diabetic diet \nand FSBG checks. His sugars remained stable on serum checks. \n\nCHRONIC/STABLE ISSUES:\n======================\n#Paroxsymal A fib\nCHADS2VASC: ___ \nOf note patient reported that he was just started on metoprolol \n25 mg daily after visit with Dr. ___ on ___. Prior to \nthat he had been taking it PRN for elevated rates at home. On \nadmission, the patient was in NSR. He was continued on his \nmetoprolol, which required uptitration to 50 mg while in house \ndue to RVR. He was discharged back on his home dose. He was \ncontinued on apixiban. \n\n#HTN: Continued on home Lisinopril 20 mg tablet daily\n\n#Gout: Dose adjusted allopurinol ___ mg tablet once daily in \nsetting of renal dysfunction.\n\n#CKD \nCr was ear baseline throughout hospitalization. Discharge Cr \n2.2. Please recheck labs in the next ___ days to ensure \nimproving.\n\nTRANSITIONAL ISSUES\n===================\n- Prednisone taper: \n___: 30 mg\n___: 20 mg\n___: 20 mg\n___: 10 mg\n___: 10 mg\n___: 10 mg\n___: 10 mg\n___: 10 mg\n___: 10 mg\n___: 10 mg\n- Adjusted allopurinol to 150 mg daily for renal function \n- Patient was noted to aspirate on food, most likely in the \nsetting of tachypnea and increased work of breathing. He was \nevaluated by speech and swallow without any concerns. \n- Recommended outpatient swallow video study if symptoms \npersist. \n\nMr. ___ is clinically stable for discharge today. The total \ntime spent today on discharge planning, counseling and \ncoordination of care was greater than 30 minutes.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lisinopril 20 mg PO DAILY \n2. Sodium Bicarbonate 650 mg PO BID \n3. Allopurinol ___ mg PO DAILY \n4. Tiotropium Bromide 1 CAP IH DAILY \n5. Metoprolol Succinate XL 25 mg PO DAILY \n6. Apixaban 2.5 mg PO BID \n7. GuaiFENesin ER 600 mg PO Q12H \n8. Torsemide 20 mg PO DAILY \n9. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID \n10. Vitamin B Complex 1 CAP PO DAILY \n11. Vitamin D ___ UNIT PO DAILY \n12. PreserVision AREDS (vitamins  A,C,E-zinc-copper) \n___ unit-mg-unit oral BID \n13. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation \nQAM \n14. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing \n\n \nDischarge Medications:\n1.  PredniSONE 20 mg PO DAILY Duration: 2 Doses \nTapered dose - DOWN  \n2.  PredniSONE 30 mg PO DAILY Duration: 2 Doses \nTapered dose - DOWN  \n3.  PredniSONE 10 mg PO DAILY Duration: 2 Doses \nTapered dose - DOWN  \n4.  Sodium Chloride 0.9%  Flush ___ mL IV DAILY and PRN, line \nflush  \n5.  Allopurinol ___ mg PO DAILY  \n6.  GuaiFENesin ER 1200 mg PO BID  \n7.  Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing  \n8.  Apixaban 2.5 mg PO BID  \n9.  Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID  \n10.  Lisinopril 20 mg PO DAILY  \n11.  Metoprolol Succinate XL 25 mg PO DAILY  \n12.  PreserVision AREDS (vitamins  A,C,E-zinc-copper) \n___ unit-mg-unit oral BID  \n13.  ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation \nQAM  \n14.  Sodium Bicarbonate 650 mg PO BID  \n15.  Tiotropium Bromide 1 CAP IH DAILY  \n16.  Torsemide 20 mg PO DAILY  \n17.  Vitamin B Complex 1 CAP PO DAILY  \n18.  Vitamin D ___ UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nCommunity-acquired Pneumonia \nAcute on chronic COPD exacerbation \nType II Diabetes Mellitus \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to ___ with pneumonia which led to a \nworsening of your emphysema. We treated you with intravenous \nantibiotics and you had a PICC line placed. We started you on \ntreatment with steroids and nebulizers to help with inflammation \nin your lungs. You also received daytime oxygen to help your \nbreathing and medication to help your cough. \n\nOver the course of your admission, your breathing improved and \nyour pneumonia was treated. Your medical team has determined \nthat it is safe for you to go home. You finished your course of \nantibiotics and had your PICC line removed. You will need to \nfinish your course of steroids at home and continue taking your \nnebulizer treatments. It is ok for you to use daytime oxygen as \nyou continue to recover. \n\nPlease follow-up with your pulmonologist and primary care \nprovider within the next ___ days. \n\nIt was a pleasure caring for you!\n\nWishing you the best,\n\nYour ___ Team\n \nFollowup Instructions:\n___\n"
}